ERBB2 and breast carcinoma: Notably, GRK2 protein levels are increased in a variety of breast cancer cell lines, in spontaneous mammary tumors developing in MMTV-HER2 transgenic mice, and in a significant proportion of two independent groups of invasive ductal carcinoma patients [111], in which luminal subtypes predominate.